Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Institut national de la recherche scientifique

$25,000.00

Isolating and characterizing lytic bacteriophages for applied use against pathogenic Escherichia coli

EF 2016-17

Résumé
Bacteria are a major burden to animal health, food safety, and public health worldwide. There has been anincrease in bacterial resistance to antibiotics and the use of antibiotics for both prevention and treatment oflivestock and poultry has been questioned due to likelihood of increased antimicrobial resistance. There is thusa growing need to develop alternative strategies to reduce and control bacterial pathogens for agriculture andfood safety. Lytic bacteriophages (phages) are bacteria-specific viruses that can lyse and kill their bacterialtargets. Bacteriophage therapy has witnessed a revival, and one of the focuses of the partnering companySyntBioLab Inc. is to develop applications to reduce and control bacterial pathogens by using phages.Escherichia coli is a major problem for food safety and animal health. In particular, for the poultry industry,avian pathogenic E. coli (APEC) is one of the predominant causes of respiratory and systemic infection ofpoultry worlwide and is responsible for major economic losses. There are numerous types of E. coli strains thatcause infections in poultry and it is therefore a challenge to thoroughly characterize a series of bacteriophagesthat will have a broad enough spectrum against a diversity of APEC strains, while demonstrating efficacy in thechicken intestinal and respiratory system by reducing E. coli colonization and preventing the development of E.coli infection (colibacillosis). We will use a diversity of characterized APEC strains from our collection tocharacterize the lytic bacteriophages and test their lytic capacity in vivo and in conditions that would mimic theenvironment in the chicken intestine or during systemic infection. This project will be done in directcollaboration with SyntBioLab Inc. combining our expertise with pathogenic E. coli and the know-how andexpertise developed by SyntBioLab Inc. for isolation and purification of bacteriophages from environmentalsources such as wastewater, poultry feces, and watershed close to agricultural facilities as well as theirexpertise in bioinformatics to analyze the phage genomes to confirm their safety for use in the livestock andfood industry.
Programme
Engage Grants Program
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
507077-2016
Name nom
Dozois, Charles
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Isolating and characterizing lytic bacteriophages for applied use against pathogenic Escherichia coli
Keyword
NSERC
Application summary
Bacteria are a major burden to animal health, food safety, and public health worldwide. There has been anincrease in bacterial resistance to antibiotics and the use of antibiotics for both prevention and treatment oflivestock and poultry has been questioned due to likelihood of increased antimicrobial resistance. There is thusa growing need to develop alternative strategies to reduce and control bacterial pathogens for agriculture andfood safety. Lytic bacteriophages (phages) are bacteria-specific viruses that can lyse and kill their bacterialtargets. Bacteriophage therapy has witnessed a revival, and one of the focuses of the partnering companySyntBioLab Inc. is to develop applications to reduce and control bacterial pathogens by using phages.Escherichia coli is a major problem for food safety and animal health. In particular, for the poultry industry,avian pathogenic E. coli (APEC) is one of the predominant causes of respiratory and systemic infection ofpoultry worlwide and is responsible for major economic losses. There are numerous types of E. coli strains thatcause infections in poultry and it is therefore a challenge to thoroughly characterize a series of bacteriophagesthat will have a broad enough spectrum against a diversity of APEC strains, while demonstrating efficacy in thechicken intestinal and respiratory system by reducing E. coli colonization and preventing the development of E.coli infection (colibacillosis). We will use a diversity of characterized APEC strains from our collection tocharacterize the lytic bacteriophages and test their lytic capacity in vivo and in conditions that would mimic theenvironment in the chicken intestine or during systemic infection. This project will be done in directcollaboration with SyntBioLab Inc. combining our expertise with pathogenic E. coli and the know-how andexpertise developed by SyntBioLab Inc. for isolation and purification of bacteriophages from environmentalsources such as wastewater, poultry feces, and watershed close to agricultural facilities as well as theirexpertise in bioinformatics to analyze the phage genomes to confirm their safety for use in the livestock andfood industry.
Institut national de la recherche scientifique - $25,… | Canada Spends